N
Notch Therapeutics
Notch Therapeutics - Notch Therapeutics
About Notch Therapeutics
Notch Therapeutics is a biotechnology startup with offices in Vancouver, Seattle, and Toronto. The company operates in the healthcare sector, specifically in the field of cell therapy. Notch's primary focus is on developing innovative treatments for various diseases, leveraging the power of stem cells. The company's operations are based on the traditional territories of several First Nations, acknowledging their ancestral rights and expressing gratitude for their stewardship of the land.
Notch Therapeutics serves a broad range of clients, including healthcare providers and patients suffering from diseases that could potentially be treated with cell therapy. The company operates in the global healthcare market, which is continually expanding due to the increasing prevalence of chronic diseases and the growing demand for innovative treatments.
The business model of Notch Therapeutics is based on research and development of novel cell therapies. The company invests heavily in scientific research to develop new treatments, which are then patented and sold to healthcare providers. The company generates revenue through the sale of these innovative therapies, as well as through partnerships with other companies in the healthcare sector.
In summary, Notch Therapeutics is a biotech startup that operates in the healthcare market, focusing on the development and sale of innovative cell therapies. The company serves healthcare providers and patients, generating revenue through the sale of its treatments and partnerships with other healthcare companies.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2018
- Headquarters
- Toronto, Canada
- Employees
- 9
- Open positions
- None listed
- Dealroom signal
- 60.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Feb 2021 | $85M | $340M | Allogene Therapeutics · Samsara BioCapital · Amplitude Ventures · Casdin Capital | ↗ |
| SEEDOther financing | Nov 2019 | $1M | $4M | Undisclosed | — |
Growth signals
Latest recorded traffic for Notch Therapeutics is 1.5K monthly website visits, up 167.9% over the last three months. Notch Therapeutics's team declined 50% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Allogene Therapeutics
Samsara BioCapital
Amplitude Ventures
Casdin Capital
EcoR1 Capital
Lumira Ventures- CHCCRM Enterprises Holdings
Other known investors1 additional known investor
University of Toronto
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Notch Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Notch Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.